Henlius Finds Global Partner For Ophthalmic Bevacizumab

Strikes Deal With Essex Bio-Technology For Biosimilar Avastin Rival

 
• By David Wallace
  
Eye
Henlius and Essex will collaborate on the biosimilar for ophthalmic indications • Source: Shutterstock

More from Biosimilars

More from Products